U.S. stocks finished mixed Wednesday, with the Nasdaq Composite gaining around 150 points. LuxExperience BV-ADR (NYSE:LUXE) shares jumped 13.5% to $8.10 after fourth-quarter sales of $771.703 million exceeded the $727.390 million analyst consensus, although its 21-cent-per-share loss was wider than the expected 14 cents. Other gainers included Einride, Forgent Power Solutions, Cipher Digital, Beta Bionics, New Found Gold, Alvotech, CURRENC Group, AXT, Worthington Enterprises, Semtech, Twist Bioscience, Bruker, Illumina and Intel. Einride received a Buy rating and an $8 price target from Canaccord Genuity analyst George Gianarikas; Barclays analyst Glen Santangelo upgraded Alvotech to Overweight and raised its price target to $8. Worthington said it will hold its quarterly earnings conference call on Wednesday, Sept. 23, while Twist Bioscience announced an agreement with Lilly TuneLab to advance antibody drug discovery. Intel shares rose amid reports that SK hynix is discussing a potential deal to bring its memory-chip production to the U.S. for the first time.